Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Apr 11, 2024	Statement of changes in beneficial ownership of securities	4	View HTML 0001867096-24-000043.pdf 0001867096-24-000043.rtf 0001867096-24-000043.xls
Nov 10, 2020	Tender offer schedule and amendment filed by the issuer.	SC TO-I	View HTML 0001193125-20-290340.pdf 0001193125-20-290340.rtf 0001193125-20-290340.xls
Oct 15, 2021	Termination of registration under Section 12(g) or suspension of duty to file reports	15-12B	View HTML 0001193125-21-300050.pdf 0001193125-21-300050.rtf 0001193125-21-300050.xls
Jul 09, 2021	UPLOAD	UPLOAD	View HTML 0000000000-21-008506.pdf 0000000000-21-008506.rtf
Aug 08, 2019	UPLOAD	UPLOAD	View HTML 0000000000-19-012227.pdf 0000000000-19-012227.rtf
May 30, 2018	UPLOAD	UPLOAD	View HTML 0000000000-18-016574.pdf
Jun 14, 2018	UPLOAD	UPLOAD	View HTML 0000000000-18-018269.pdf
Feb 08, 2019	UPLOAD	UPLOAD	View HTML 0000000000-19-001649.pdf 0000000000-19-001649.rtf
Jun 05, 2018	UPLOAD	UPLOAD	View HTML 0000000000-18-017206.pdf
May 11, 2018	UPLOAD	UPLOAD	View HTML 0000000000-18-014705.pdf

Data provided by Kaleidoscope.